CD21 lo/neg B cells are elevated in SSc ILD patients, but NOT in SSc patients without ILD, nor in healthy controls.CD21 lo/neg B cells are possibly potent CD4+ T cells activators, previously described as Th17 activators in mice. This evidence concerns the gene CR2 and systemic sclerosis.